SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-070131
Filing Date
2024-03-18
Accepted
2024-03-18 16:06:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d784332d424b3.htm 424B3 472688
2 GRAPHIC g784263g0317122432784.jpg GRAPHIC 3643
3 GRAPHIC g784332g0318022209601.jpg GRAPHIC 3642
  Complete submission text file 0001193125-24-070131.txt   484207
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-273769 | Film No.: 24759022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)